Trimethoprim-Sulphamethoxazole in Acute Brucellosis

Abstract

Eight patients with proved brucella infection were treated with trimethoprim-sulphamethoxazole. The dose varied from two to four tablets given twice daily for three weeks. Clinical response was rapid and all patients were asymptomatic and afebrile within two to seven days of starting therapy. Three patients relapsed clinically and bacteriologically within three weeks of ending treatment. It is suggested that the treatment be continued for at least six weeks to prevent relapses.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 1971
Accession Number
AD0750230

Entities

People

  • A. Hassan
  • K. Sorensen
  • M. M. Erian
  • S. D. Hathout
  • Z. Farid

Organizations

  • Naval Medical Research Unit Three

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Biomedical Research
  • Brucellosis
  • Classification
  • Gram-Negative Bacterial Infections
  • Health
  • Health Services
  • Infection
  • Intellectual Property
  • Law
  • Navy
  • New York
  • Public Health
  • Side Effects
  • Therapy
  • Tropical Medicine
  • United Kingdom

Fields of Study

  • Medicine

Readers

  • Immunology
  • Oncology
  • Toxicology/Environmental Toxicology